Matches in Nanopublications for { ?s ?p "[Taken together, these results suggest that erlotinib inhibits human NSCLC cell growth predominantly by inducing p27(KIP1) expression and by suppressing cell-cycle events involved in the G1/S transition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP606327.RAOY8ekG7yU8kKcbExNy-3QJqeaFOOd0P_Y8T_m4nNKtU130_assertion description "[Taken together, these results suggest that erlotinib inhibits human NSCLC cell growth predominantly by inducing p27(KIP1) expression and by suppressing cell-cycle events involved in the G1/S transition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606327.RAOY8ekG7yU8kKcbExNy-3QJqeaFOOd0P_Y8T_m4nNKtU130_provenance.
- NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_assertion description "[Taken together, these results suggest that erlotinib inhibits human NSCLC cell growth predominantly by inducing p27(KIP1) expression and by suppressing cell-cycle events involved in the G1/S transition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.